Elman Retina Group, P.A.
Elman Retina Group, P.A.
Baltimore, Maryland, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR | Proliferative Diabetic Retinopathy (PDR) | Recruiting | Phase 3 | 2026-09-18 | NCT06790784 | |
| Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM | eye disorder, preretinal fibrosis, retinal disorder | Recruiting | Not applicable | 2026-07-16 | NCT05145491 | |
| Fenofibrate for Prevention of DR Worsening | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-06-29 | NCT04661358 |